Levi & Korsinsky Announces The Chemours Company Class Action Investigation; CC Lawsuit
Levi & Korsinsky, LLP
October 25, 2019
Levi & Korsinsky, LLP announces that a CC class action lawsuit has been commenced on behalf of investors who purchased The Chemours Company, (CC) securities between February 16, 2017 and August 1, 2019. For more on the The Chemours Company Class Action please contact us today.
According to the The Chemours Company lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company’s policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours’ handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.
TO LEARN MORE ABOUT THE CC CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/the-chemours-company-loss-form?wire=3
If you suffered a loss in The Chemours Company you have until December 9, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171